Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2003-12-5
pubmed:abstractText
Combined liver-kidney transplantation is the definitive treatment for end-stage renal disease caused by primary hyperoxaluria type I (PH1). The infantile form is characterized by renal failure early in life, advanced systemic oxalosis, and a formidable mortality rate. Although others have reported on overall results of transplantation for PH1 covering a wide age spectrum, none has specifically addressed the high-risk infantile form of the disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0041-1337
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1458-63
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14657686-Body Constitution, pubmed-meshheading:14657686-Body Mass Index, pubmed-meshheading:14657686-Creatinine, pubmed-meshheading:14657686-Follow-Up Studies, pubmed-meshheading:14657686-Graft Rejection, pubmed-meshheading:14657686-Graft Survival, pubmed-meshheading:14657686-Growth, pubmed-meshheading:14657686-Humans, pubmed-meshheading:14657686-Hyperoxaluria, Primary, pubmed-meshheading:14657686-Infant, pubmed-meshheading:14657686-Infection, pubmed-meshheading:14657686-Kidney Transplantation, pubmed-meshheading:14657686-Liver Transplantation, pubmed-meshheading:14657686-Oxalates, pubmed-meshheading:14657686-Postoperative Complications, pubmed-meshheading:14657686-Reproducibility of Results, pubmed-meshheading:14657686-Retrospective Studies, pubmed-meshheading:14657686-Survival Rate, pubmed-meshheading:14657686-Time Factors, pubmed-meshheading:14657686-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience.
pubmed:affiliation
Stanford University School of Medicine, Palo Alto, CA 94304, USA. mmillan@stanford.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't